Trials / Completed
CompletedNCT02323490
Augmentation of Meniscal Repair With Marrow Stimulation Techniques (Microfractures)
Augmentation of Meniscal Repair With Bone Marrow Stimulation Techniques (Microfractures): a Double Blind, Prospective, Randomized Clinical Trial of Efficacy and Safety.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Centre of Postgraduate Medical Education · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare meniscal healing augmented or without augmentation with bone marrow stimulation techniques The assessments will include validated, disease specific, patient oriented outcome measures, second look arthroscopy during second step ACL reconstruction. Results of this study will help ascertain whether microfractures improve meniscal healing rates.
Detailed description
The role of meniscal in the knee integrity is pivotal and lack or partial role of the meniscus increases rate of joint degeneration. Partial meniscal removal is the most popular procedure and meniscal repair remain in minority of arthroscopic surgeries. As criteria of inclusion to meniscal repair are very rough, still success rates of meniscal repair remain in the 60-80% range for isolated repairs. This rate is greater when performed with ACL reconstruction. We believe that augmentation with bone marrow stimulation techniques will induce more complete and possibly faster healing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | with microfractures | following meniscal repair, microfractures will be created on the intercondylar and outer part of femoral condyle (outside of joint surface), lateral or medial, respectively |
| PROCEDURE | without microfractures | standard procedure meniscal repair without augmentation. |
Timeline
- Start date
- 2013-08-19
- Primary completion
- 2016-02-01
- Completion
- 2018-04-01
- First posted
- 2014-12-23
- Last updated
- 2018-06-12
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT02323490. Inclusion in this directory is not an endorsement.